Clinical Trial Update: Effectiveness of Escitalopram in the Treatment of Body Dysmorphic Disorder [Phase 3]

View source ↗

Summary

This Phase 3 trial assessed the effectiveness of escitalopram for body dysmorphic disorder; results have been completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Body Dysmorphic Disorder
• Somatic Symptom Disorder

Drugs mentioned

• Lexapro (escitalopram)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Anxiety Disorders, Somatoform Disorders | Phase 3 | Status: COMPLETED | Results posted: 2014-11-21